Cadent Therapeutics

Cadent Therapeutics

Cadent Therapeutics

Cognitive and Movement Disorders Affect Millions We are rapidly advancing a pipelineof novel allosteric modulators of ion channels taking a wellestablished pharmaceutical approach and stepping out into new territory.SK channels and NMDA receptors are ion
Raised
$40M
Follow us
Alexa global traffic share
Twitter followers
15 Nov 2018
$40,000,000
Venture capital (Series B)

Cadent Therapeutics Secures $40M Series B Financing

FinSMEs
+1